Equillium Inc. (EQ)
NASDAQ: EQ
· Real-Time Price · USD
1.23
-0.04 (-3.15%)
At close: Oct 16, 2025, 3:59 PM
1.22
-0.81%
After-hours: Oct 16, 2025, 06:31 PM EDT
-3.15% (1D)
Bid | 1.17 |
Market Cap | 43.69M |
Revenue (ttm) | 16.55M |
Net Income (ttm) | -20.19M |
EPS (ttm) | -0.57 |
PE Ratio (ttm) | -2.16 |
Forward PE | -4.13 |
Analyst | Hold |
Dividends | n/a |
Ask | 1.28 |
Volume | 925,932 |
Avg. Volume (20D) | 7,942,756 |
Open | 1.25 |
Previous Close | 1.27 |
Day's Range | 1.17 - 1.27 |
52-Week Range | 0.27 - 2.35 |
Beta | 1.53 |
Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for EQ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+78.88%
Equillium shares are trading higher after the comp...
Unlock content with
Pro Subscription
2 months ago
+81.59%
Shares of energy stocks are trading lower as oil prices fall on demand concerns amid US tariffs.

2 months ago · businesswire.com
Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve StrategyLA JOLLA, Calif.--(BUSINESS WIRE)-- #Bitcoin--Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced ...